Status:
COMPLETED
Kidney Disease After COVID-19
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
New Jersey Medical School
University of Michigan
Conditions:
COVID-19
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
To understand the long-term epidemiology, develop effective risk-prediction and stratification tools, and understand the pathobiology of kidney disease in COVID-19 survivors.
Eligibility Criteria
Inclusion
- Criteria:
- Adults, age ≥18 years
- Confirmed diagnosis of COVID-19
Exclusion
- • No confirmed diagnosis of COVID-19
Key Trial Info
Start Date :
January 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 4 2024
Estimated Enrollment :
1753 Patients enrolled
Trial Details
Trial ID
NCT05328986
Start Date
January 4 2020
End Date
January 4 2024
Last Update
July 20 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale School of Medicine
New Haven, Connecticut, United States, 06513
2
Johns Hopkins University
Baltimore, Maryland, United States, 21287
3
University of Michigan
Ann Arbor, Michigan, United States, 48105
4
New Jersey Medical School - Rutgers University
Newark, New Jersey, United States, 07103